ALKERMES | Netto Inntekt



Net Income Endring Dato
AbbVie USD 1.29B 1.31B 2025-03
Acadia Pharmaceuticals USD 143.74M 110.98M 2024-12
ALKERMES USD 367.07M 274.69M 2024-12
Amgen USD 627M 2.2B 2024-12
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
J&J USD 11B 7.57B 2025-03
Malin Corporation EUR 0 1.1M 2024-06
Merck USD 5.08B 1.34B 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Otsuka Holdings JPY 85B 66.45B 2025-03
Pfizer USD 2.97B 2.56B 2025-03
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



ALKERMES Netto Inntekt - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.